A recent report published by Infinium Global Research on
cranial doppler market provides an in-depth analysis of segments and sub-segments
in the global as well as regional cranial doppler market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional cranial doppler market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecasts, and dollar
values of the global cranial doppler market. According to the report, the global
cranial doppler market is projected to grow at a CAGR of 6.7% over the forecast
period of 2020-2026.
Cranial Doppler’s are non-invasive ultrasound (US) device
that is used to measure the cerebral blood flow velocity in the major
intracranial arteries. Majorly, cranial Doppler is the most convenient way to
monitor vascular changes in response to interventions during acute
cerebrovascular events. Cranial Doppler helps in correctly diagnosing the
neurological disease. The Doppler provides real-time measurement, which is used
to monitor blood flow changes in the brain. It uses sound waves to produce
results. The cranial Doppler diagnosis is preferred over other diagnosis
systems as it gives more accurate results with reduced time for the process.
The current concerns over the spread of coronavirus are
expected to have a positive impact on the growth of the cranial doppler market
as the cranial doppler system helps to identify blood flow in the brain in
real-time. During such COVID-19 pandemic, where the number of patients is
increasing drastically and it is very important to reduce the spread of
infection. However, the device allows clinicians to swiftly identify blood
clots in COVID-19 patients, and then implement timely treatment. This will
boost the demand of cranial doppler in the market. Further, the rise in usage of
the system in the hospitals to identify which patients are at higher risk of
vascular complications. Furthermore, a rapid focus on research and development to
improve the outcome of COVID-19 patients through assessment and monitoring of
blood flow through the brain will boost the demand of cranial doppler in the
near future.
The global rise in the number of geriatric patient’s population
suffering from the neurological disorder is the main key factor driving the global
cranial Doppler market. Recent expansion
in the number of clinics for cerebrovascular diagnosis which provides various
treatment methods are increasing the demand for the cranial Doppler market.
Additionally, rising government support for research and development activities
on cerebrovascular diagnosis and treatment is also propelling the market growth
in the forecast period. Growing enhancements in the healthcare system for
analyzing diseases effectively is another important factor driving the growth
of the market. Further, growing global public health prominence of common
neurological disorders such as neuro-infections, headache disorders, disorders
associated with malnutrition, stroke, and traumatic brain injuries propelling
the growth of the cranial Doppler market. Annually, 1.2 million were diagnosed with
adult-onset brain disorders accounts for up to 50% all neurological disorder, and 21% are due to stroke and Alzheimer’s disease, respectively. However, the
lack of skilled expertise for diagnosis and treatment of neurological disorders
in some emerging countries hampers the market growth. Additionally, cranial
Doppler is also used in the diagnosis of brain stem death, head injury, raised
intracranial pressure (ICP), intraoperative monitoring drive the market in the
near future.
Geographically, North America holds the largest share in the
global market and expected to continue its dominance over the forecast
period. The high spending capacity of the
population in the U.S contributes to the growth of the cranial Doppler market in
the North America region. According to the Federal Interagency Forum on
Neurological Disorders, nearly 35% of people aged 85 years and older experience
moderate or severe memory damage in the U.S. The market in Europe is expected
to escalate owing to the rising prevalence of neurological diseases and high
adoption of advanced technology. Furthermore, a well-established healthcare
structure and increasing government funding for research and development are
also supporting the growth of the market. The Asia Pacific is expected to grow
at a steady rate due to the rapidly aging population. In Japan, currently, one-quarter of its
population is above 65 whereas, Taiwan, China, Korea, and Singapore are
anticipated to experience rapid aging.
The report on the global cranial doppler market covers segments
such as type and application. On the basis of type, the sub-markets include
imaging and non-imaging. On the basis of application, the sub-markets include
sickle cell disease, acute ischemic stroke, intracranial steno occlusive
disease, and others.
The report provides profiles of the companies in the market
such as Integra Lifesciences, Spiegeberg GmbH &Co., Nihon Kohden
Corporation, Elekta, Rimed Ltd., CAS Medical system, Inc., Atys Medical,
Shenzhen Delica Medical Equipment, Neural Analytics, and Natus Medical.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the cranial doppler
market. Moreover, the study highlights current market trends and provides
forecast from 2020-2026. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.